Indaptus Therapeutics, Inc. announced the successful closing of its previously disclosed private placement, raising approximately $24.0 million in gross proceeds.
Key Details
- Gross Proceeds: The company received approximately $24.0 million before deducting offering expenses.
- Shares Issued: A total of 20,338,974 shares of common stock were issued to the purchasers.
- Closing Date: The transaction was completed on October 16, 2026, in accordance with the Stock Purchase Agreement dated September 8, 2026.